Haoyue Care(SH:605009) Jing Ji Guan Cha Wang·2026-02-12 08:49Group 1 - The core viewpoint indicates that Haoyue Care (605009) has shown revenue growth but profit pressure, with 2025 revenue at 2.718 billion yuan, up 33.18%, while net profit decreased by 30.94% to 203 million yuan [1] - The gross margin improved by 11.97 percentage points to 31.7%, but operating cash flow per share dropped significantly by 81.06% to 0.31 yuan, highlighting challenges in operational efficiency [1] - Institutions predict a 7.87% decline in net profit for 2025, but a potential recovery of 15.94% growth in 2026, emphasizing the need to monitor cash flow improvements for long-term fundamentals [1] Group 2 - Institutional ratings for Haoyue Care are generally neutral, with a target price of 49.00 yuan, indicating a potential upside of 58.78% from the current stock price [2] - Revenue is expected to reach 3.872 billion yuan in 2025, a year-on-year increase of 32.18%, although net profit growth remains under pressure; a rebound in net profit growth to 15.94% is anticipated for 2026 [2] - Current institutional research frequency is low, with fund ownership at only 0.05%, suggesting average market attention and the need to monitor future performance [2] Group 3 - Over the past 7 trading days (February 6 to 12, 2026), Haoyue Care's stock price has fluctuated downwards, with a total decline of 3.18%, including a single-day drop of 2.29% to 30.71 yuan on February 12 [3] - On that day, there was a net outflow of 6.0281 million yuan from major funds, while retail investors dominated the inflow [3] - Technical indicators show the stock price nearing the lower Bollinger Band support level of 30.36 yuan, with a weak MACD indicator, necessitating attention to support around 30.46 yuan in the short term [3]